SAMSARA BIOCAPITAL, LLC: 13F holdings
CIK 17449672026Q2
| Positions | 24 |
|---|
| Reported value | $1.2bn |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 24 (+2 vs prior quarter) |
|---|
| Reported value | $1.2bn (+18.3%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| SRRK SCHOLAR ROCK HLDG CORP | 6,897,652 | $379.4m | 31.2% |
| ALMS ALUMIS INC | 6,345,219 | $178.6m | 14.7% |
| MLYS MINERALYS THERAPEUTICS INC | 5,871,018 | $158.4m | 13.0% |
| SEPN SEPTERNA INC | 3,149,128 | $105.5m | 8.7% |
| ALAMAR BIOSCIENCES INC | 2,480,310 | $67.2m | 5.5% |
| NGNE NEUROGENE INC | 1,717,127 | $54.0m | 4.4% |
| KALARIS THERAPEUTICS INC | 12,881,175 | $52.4m | 4.3% |
| SPYGLASS PHARMA INC | 2,109,953 | $47.0m | 3.9% |
| SUTRO BIOPHARMA INC | 1,062,872 | $35.3m | 2.9% |
| INVENTIVA SA | 6,314,805 | $23.9m | 2.0% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1744967")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples